Skip to content

CXI G23864Recalls & reported problems

Cook Incorporated · CXI Support Catheter · Class 2

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00827002238640), received between Oct 24, 2025 and Oct 24, 2025 — classified as 1 malfunction.

The most frequently reported specific device problem is “Break” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 1 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Break1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionOct 24, 2025Break; Break

    ADDITIONAL INFORMATION WAS RECEIVED 24OCT2025. THE PROCEDURE INVOLVED MULTIPLE INTERVENTIONS INCLUDING INTRAVASCULAR LITHOTRIPSY, PERCUTANEOUS TRANSLUMINAL BALLOON ANGIOPLASTY, AND STENT PLACEMENT. THE PATIENT HAD MULTI-LEVEL AORTOILIAC OCCLUSIVE DISEASE OF THE RIGHT LOWER EXTREMITY, AND THE RIGHT SUPERFICIAL FEMORAL AND POSTERIOR TIBIAL ARTERIES WERE OCCLUDED. ACCESS WAS OBTAINED IN THE LEFT FEMORAL ARTERY TO TARGET THE RIGHT LOWER EXTREMITY, DOWN TO THE POSTERIOR TIBIAL ARTERY. THE CATHETER WAS ADVANCED THROUGH ANOTHER MANUFACTURER¿S 45-CENTIMETER SHEATH, AND MULTIPLE WIRES WERE USED DURING THE PROCEDURE. IT IS UNKNOWN IF RESISTANCE WAS ENCOUNTERED UPON INSERTION OR ADVANCEMENT OF THE CATHETER. A POWER INJECTOR WAS NOT USED. THE DEVICE SEPARATED IN THE MIDDLE OF THE PROCEDURE. IT IS UNKNOWN WHAT WAS ATTACHED TO THE HUB AT THE TIME OF THE EVENT. THE CATHETER WAS MANUALLY REMOVED FROM THE PATIENT. THE PROCEDURE WAS COMPLETED SUCCESSFULLY, WITH IN-LINE FLOW VIA PERONEAL ARTERY RUNOFF WITH MULTI-PHASIC PEDAL DOPPLER SIGNALS AFTER THE INTERVENTIONAL PROCEDURE. A SECTION OF THE DEVICE DID NOT REMAIN INSIDE THE PATIENT¿S BODY. THE PATIENT DID NOT REQUIRE ANY ADDITIONAL PROCEDURES OR EXP

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 23378661 ↗

Other Catheter, continuous flush devices

All Catheter, continuous flush devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.